Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SenesTech, Inc. (SNES)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5073+0.0273 (+1.84%)
At close: 4:00PM EDT
1.5200 +0.01 (+0.84%)
After hours: 05:49PM EDT
Advertisement

SenesTech, Inc.

23460 North 19th Avenue
Suite 110
Phoenix, AZ 85027
United States
928 779 4143
http://www.senestech.com

Sector(s)Basic Materials
IndustrySpecialty Chemicals
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Mr. Kenneth S. SiegelCEO & Director296.25kN/A1956
Mr. Thomas C. ChestermanExec. VP, CFO, Treasurer & Assistant Sec.246.32kN/A1959
Ms. Kim Patrice WolinExec. VP of Operations & Sec.90.84kN/A1955
Dr. Steven C. Krause Ph.D.Exec. VP of Sales & Marketing240.33kN/A1960
Mr. Paul M. PalzVP & Corp. ControllerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Corporate Governance

SenesTech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement